Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine production-Reference-Cited by-同舟云学术

Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine production

Published:2020-06-02 Issue:6 Volume:19 Page:507-527
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Dow Jennifer Mhairi¹,Mauri Marta¹^ORCID,Scott Timothy Alexander¹,Wren Brendan William¹

Affiliation:

1. Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2020.1775077

Reference137 articles.

1. World Health Organization. Global action plan on antimicrobial resistance [Internet]. 2017. [cited 2019 Dec 6]. Available from: https://www.who.int/antimicrobial-resistance/global-action-plan/en/

2. CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS

3. Interim Report of a Controlled Field Trial of Immunization with Capsular Polysaccharides of Haemophilus influenzae Type band Group C Neisseria meningitidis in Mecklenburg County, North Carolina (March 1974-March 1976)

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacterial glycoengineering: Cell-based and cell-free routes for producing biopharmaceuticals with customized glycosylation;Current Opinion in Chemical Biology;2024-08

2. Evolution of paralogous multicomponent systems for site-specific O-sialylation of flagellin in Gram-negative and Gram-positive bacteria;Current Biology;2024-07

3. Determining glycosyltransferase functional order via lethality due to accumulated O-antigen intermediates, exemplified with Shigella flexneri O-antigen biosynthesis;Applied and Environmental Microbiology;2024-06-18

4. Investigation into the efficiency of diverse N‐linking oligosaccharyltransferases for glycoengineering using a standardised cell‐free assay;Microbial Biotechnology;2024-06

5. Efficient Production of Self-Assembled Bioconjugate Nanovaccines against Klebsiella pneumoniae O2 Serotype in Engineered Escherichia coli;Nanomaterials;2024-04-21